Human glomerular mesangial cells express CD16 and may be stimulated via this receptor

M Morcos1, G M Hänsch, M Schönermark

  • 1Institute of Immunology and Serology, Medical Faculty of Mannheim, University of Heidelberg, Germany.

Kidney International
|December 1, 1994
PubMed

Insights

Human glomerular mesangial cells (GMC) express CD16, a receptor for IgG. This receptor may play a role in kidney inflammation by mediating interleukin-6 release upon immune complex binding.

Area of Science:

  • Immunology
  • Nephrology
  • Cell Biology

Background:

  • CD16 is a low-affinity IgG receptor found on various immune cells.
  • Glomerular mesangial cells (GMCs) are crucial for kidney function and filtration.
  • The presence and function of CD16 in GMCs are not well-understood.

Purpose of the Study:

  • To investigate the expression and characterization of CD16 on human glomerular mesangial cells (GMCs).
  • To determine the functional role of CD16 in GMCs, particularly in response to immune complexes.
  • To explore the potential involvement of GMC CD16 in inflammatory kidney diseases.

Main Methods:

  • Western blot analysis, cell ELISA, and in situ hybridization to detect CD16 expression.
  • Reverse polymerase chain reaction (RT-PCR) and sequence analysis for molecular characterization.
  • Stimulation assays with aggregated gammaglobulin and monoclonal antibodies to CD16.
  • Measurement of interleukin-6 release as a functional readout.

Main Results:

  • CD16 was detected on cultured human GMCs using multiple methods.
  • Sequence analysis indicated that GMC-CD16 is the transmembrane form, similar to NK-CD16.
  • CD16 expression levels did not change upon stimulation with aggregated gammaglobulin.
  • Incubation with aggregated gammaglobulin or anti-CD16 antibodies induced a dose- and time-dependent release of interleukin-6 from GMCs.

Conclusions:

  • Human GMCs express the transmembrane form of CD16.
  • CD16 signaling in GMCs can trigger the release of the pro-inflammatory cytokine interleukin-6.
  • CD16-mediated immune complex recognition by GMCs may contribute to the pathogenesis of glomerulonephritis.